"What used to take months—finding a CDMO, verifying capabilities, reaching the right contact—can now be done in minutes."

"The preference for European manufacturers in the US has grown over the past five or six years, driven by the push for geopolitical risk mitigation."

"It is the Massachusetts story — early-stage companies developing great science, commercial giants with a local presence, and financial partnerships that turn ideas into treatments."

"We have recognized the synergies between the life science and tech industries, and have worked to foster relationships that can accelerate therapeutic, medical device and diagnostic development."